11-Mar-2008 - The CEO of Californian company Nektar Therapeutics says that 2007 has been key in transforming the company into a fully integrated drug development organisation, despite the setback with Pfizer's inhaled insulin product Exubera.
Link to Article
in-pharmatechnologist.com
|
|
||||
|
This Month
Month Archive
RSS Newsfeeds
Main Page RSS
|
Tuesday, March 11
Nektar optimistic despite Exubera fallout
by
Alex Hsieh on behalf of Professor Henry Wang
on Tue 11 Mar 2008 11:03 PM EDT
China-made heparin scare spreads beyond US
by
Alex Hsieh on behalf of Professor Henry Wang
on Tue 11 Mar 2008 11:02 PM EDT
11-Mar-2008 - The made-in-China heparin scare has now spread beyond the US, with Germany and Japan both recalling the drug.
Link to Article in-pharmatechnologist.com |
Search
Links
|
||